Nearly every cell runs its own peripheral clock that times liver, pancreas and fat metabolism, and meal timing is a zeitgeber that sets these clocks.The is the master clock, but nearly every cell has its own peripheral clock — liver, pancreas, fat, muscle all run BMAL1/CLOCK/Period/Cryptochrome transcription-translation feedback loops on ~24h cycles.
These peripheral clocks regulate: liver metabolic enzyme rhythms (lipogenesis at night, gluconeogenesis by day), pancreatic insulin secretion rhythm (best glucose tolerance in the morning, worst at night), adipocyte lipolysis rhythms.
Meal timing is a zeitgeber — stronger than light for entraining peripheral clocks. When you eat calibrates liver and pancreas clocks more than what you eat.
2 · TRE · compress eating into 8-10 hours
Time-restricted eating fits all daily calories into an 8-10 hour window, and the regular feed-fast cycle keeps the peripheral clocks of different organs in sync.Time-restricted eating (): all daily calories within an 8-10 hour window (e.g., 10am-6pm), remaining 14-16h water/black coffee/tea only.
Mechanism: a regular feed-fast cycle synchronizes peripheral clocks — liver knows when to produce enzymes, fat knows when to lipolyze, muscle knows when to take up glucose.
Irregular eating (late-night snacks, eating across time zones) desynchronizes organ clocks — liver follows light, pancreas follows food, fat follows its own rhythm. This is circadian misalignment, linked to metabolic syndrome, obesity, and .
3 · Fasted state · autophagy & ketones
After 12-16 hours of fasting, liver glycogen runs out and the body shifts to fat and ketones; whether this metabolic switch adds any benefit is unsettled.After 12-16h fasting: Glycogen depleted → liver shifts to gluconeogenesis and ketogenesis (β-hydroxybutyrate)Insulin stays low → adipose lipolysis ↑ → FFAs for energyAutophagy upregulated: inhibition + activation → cellular clearance of damaged organelles and misfolded proteins This turning point is called the metabolic switch: liver glycogen runs out and fatty acids are mobilised, typically beyond 12 hours after the last meal.
Whether the switch itself adds anything is unsettled. The Anton 2018 review that named it argues it does — shifting from glucose to fatty-acid-derived ketones preserves muscle and turns on stress-resistance signalling. But that same paper closes by saying future fasting should use plasma ketones as a compliance marker to test exactly this. Even its authors write it up as a hypothesis awaiting trial.
Whether it beats simply eating less is the next step's question.
4 · Evidence reality · works but not magic
Weight loss with time-restricted eating is small to begin with, and in a 12-month trial with calories held equal, the eating window itself added no significant extra loss.This is the step to slow down on.
The weight change is small to begin with: pooling 19 trials (Moon 2020) gives body weight −0.90 kg (95% −1.71 to −0.10) and fat mass −1.58 kg with fat-free mass preserved; systolic BP −3.07 mmHg.Once calories are held equal, the window adds nothing: Liu 2022 randomised 139 adults with obesity to time-restricted eating (8am-4pm) plus calorie restriction vs calorie restriction alone, both on the same daily calorie range, for 12 months. Result: −8.0 kg vs −6.3 kg, between-group difference −1.8 kg (95% CI −4.0 to 0.4, P=0.11) — not significant, and waist, body fat and metabolic markers matched too. That trial answers the question directly: the window itself gets no extra credit.Timing may still do something else: Sutton 2018 moved the eating window to early in the day in men with prediabetes under isocaloric feeding with no weight change — insulin sensitivity ↑, blood pressure ↓, oxidative stress ↓. Only 8 participants; needs replication.Wilkinson 2020 used a 10-hour window in metabolic syndrome patients and saw improvements in weight, blood pressure and atherogenic lipids. Who may benefit: irregular eaters, night eating, metabolic syndrome.
Who should not: eating disorder history, underweight, pregnant/lactating, type 1 diabetes, anyone on glucose-lowering drugs (hypoglycemia risk) — ask a clinician first.